SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Bridgetech Holdings International Inc. , a company focused on maximizing the potential of emerging healthcare products and services in the U.S. and Asian markets, today announced that it has successfully opened its Taiwan branch office in Taipei -- Bridgetech Medicines Limited (BML). The highly anticipated grand opening included Formosa Biomedical Technology CEO Wang Jui-yu, Taipei Mayor Hau Lung-bin, National Health Research Institutes (NHRI) director Jacqueline Whang-Peng, and members of Ministry of Economic Affairs (MOEA).
"The value of the Taiwan market is tremendous," stated Michael Chermak, Chairman and CEO of Bridgetech. "The alliances with Taiwan's governmental bodies, medical research institutes, medical providers and leading companies like Formosa are allowing the company to quickly ramp up our technology transfer initiatives."
John Chen, President of Bridgetech Medicines Limited, added "We're pleased to bring CellSearch to Taiwan's oncology market. In addition, Bridgetech's base in Taiwan allows an ongoing evaluation and introduction of current and future products in our pipeline."
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at http://www.bthi.com .
Bridgetech Medicines LimitedRoom WR05., 17th floor, 3 YuanQu St., Taipei 115, Taiwan Tel: 02-2653-9013 Fax: 02-2653-8047
Forward-Looking Statements.
Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.
Bridgetech Holdings International Inc.CONTACT: media, Vince Heald of Beck Ellman Heald, +1-858-453-9600,vheald@behmedia.com; or investors, Redwood Consultants, LLC,+1-415-884-0348, both for Bridgetech Holdings International Inc.
Web site: http://www.bthi.com//
